Stocks of the Hour: Lumos Diagnostics, Kuniko, Asra Minerals, Sunstone Metals
Lumos Diagnostics (ASX:LDX) has received FDA clearance for its FebriDx product, which can rapidly differentiate viral from bacterial infections at point of care. Doug Ward, CEO commented, “With this clearance in hand, we anticipate securing our first commercial orders in the US before the end of calendar year 2023.” Shares are trading 336.36 per cent […]
Stocks of the Hour: Lumos Diagnostics, Kuniko, Asra Minerals, Sunstone Metals Read More »
